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Abstract
Background—Gut microbiota may play a role in the natural history of cow’s milk allergy
Objective—To examine the association between early life gut microbiota and the resolution of 
cow’s milk allergy
Methods—We studied 226 children with milk allergy who were enrolled at infancy in the 
Consortium of Food Allergy (CoFAR) observational study of food allergy. Fecal samples were 
collected at age 3–16 months, and the children were followed longitudinally with clinical 
evaluation, milk-specific IgE levels, and milk skin prick test performed at enrollment, 6 months, 
12 months, and yearly thereafter up until age 8 years. Gut microbiome was profiled by 16s rRNA 
sequencing and microbiome analyses performed using QIIME (Quantitative Insights into 
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Microbial Ecology), PICRUSt (Phylogenetic Investigation of Communities by Reconstruction of 
Unobserved States), and STAMP (Statistical Analysis of Metagenomic Profiles).
Results—Milk allergy resolved by age 8 years in 128 (56.6%) of the 226 children. Gut 
microbiome composition at age 3–6 months was associated with milk allergy resolution by age 8 
years (PERMANOVA P = 0.047), with enrichment of Clostridia and Firmicutes in the infant gut 
microbiome of subjects whose milk allergy resolved. Metagenome functional prediction supported 
decreased fatty acid metabolism in the gut microbiome of subjects whose milk allergy resolved 
(η2 = 0.43, ANOVA P = 0.034).
Conclusions—Early infancy is a window during which gut microbiota may shape food allergy 
outcomes in childhood. Bacterial taxa within Clostridia and Firmicutes could be studied as 
probiotic candidates for milk allergy therapy.
Keywords
cow’s milk allergy; microbiome; microbiota; Clostridia; Firmicutes; Bacteroidetes; metagenome; 
fatty acid; food allergy; 16s rRNA sequencing
Introduction
Cow’s milk allergy is the most common food allergy in young children, affecting 2–3%.1,2 
Individuals with milk allergy are at risk for allergic reactions and also face challenges in 
finding suitable replacements for the nutritional content that milk-based products provide.3 
A child may have to live with the limitations imposed by milk allergy for several years, as 
recent studies have shown that milk allergy often continues into later childhood and 
adulthood.1,4 Parents of milk allergic children often ask allergists to gauge whether their 
child’s milk allergy will resolve.
We hypothesized that gut microbiota play a role in the natural history of milk allergy, as the 
etiology of food allergy is thought to involve deviation from the default state of mucosal 
immune tolerance that may be driven by diet, commensal microbiota, and interactions 
between them.5,6 Variations in infant gut flora have been associated with allergy skin prick 
test response,7 specific IgE levels,8 atopic dermatitis,8,9 and food allergy status.10 Much of 
this previous work has relied upon culture methods, which allow for examination of species 
specifically targeted and cultured, but exclude the large majority of bacterial organisms that 
cannot be cultured. These excluded organisms may play key roles in the natural history of 
milk allergy.
In this study, we used high-throughput sequencing to comprehensively characterize the gut 
microbiota of 226 children age 3–16 months with cow’s milk allergy. We followed these 
children up to age 8 years and examined for associations between early-life gut microbiota 
diversity, composition, and milk allergy resolution.
Methods
Study protocols were approved by the institutional review boards of the participating 
institutions.
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Study design and subjects
The subjects of this study are a subset of a larger observational cohort study by the 
Consortium of Food Allergy Research (CoFAR) of 512 participants with milk allergy, egg 
allergy, and/or moderate-to-severe atopic dermatitis but without known peanut allergy.1,11 
Participants were recruited at age 3–15 months from five study centers across the United 
States and were followed over time. The study sites included the Icahn School of Medicine 
at Mount Sinai, New York, New York; Duke University School of Medical Center, Durham, 
NC; Johns Hopkins University School of Medicine, Baltimore, MD; National Jewish Health, 
Denver, CO; and Arkansas Children’s Hospital, Little Rock, AR. The goal of the CoFAR 
observational study was to identify factors associated with the development of peanut allergy 
in a high risk cohort. Examination of the natural histories of milk and egg allergy were 
secondary objectives.
We collected stool from 234 of the 244 CoFAR observational study participants who had 
milk allergy at study entry. Stool samples were collected at or near the time of enrollment. 
Samples were collected during a study visit or by the parent at home using a stool collection 
kit provided by CoFAR. For this study, we excluded from the analysis 3 subjects who 
submitted stool samples after age 17 months, yielding 231 stool samples from 231 
participants for DNA isolation.
DNA isolation and sequencing
DNA was isolated using the MoBio Power Soil DNA Isolation kit (Carlsbad, CA). The V4 
region of the 16S rRNA gene was amplified with barcoded primers and 16S rRNA 
sequencing was performed on the Illumina MiSeq platform using 2×250bp paired-end read. 
Stool samples from 5 participants yielded less than 2,000 sequences/sample (2.2% of 231 
samples sequenced) and these subjects were removed from the analysis, yielding a final 
sample size for analysis of 226 subjects. In total, 5,478,379 sequences were assigned to 16S 
rRNA gene sequences for the 226 samples, with a median of 23,682 sequences per sample.
Outcomes
Data were prospectively collected from study enrollment up through a visit at approximately 
age 8 years. Participants were considered to have milk allergy if they had either (1) positive 
physician-supervised oral food challenge or a convincing reaction and sensitization to milk 
by milk-specific IgE level ≥ 0.35 kUA/L and/or skin prick test (SPT) > 3mm, or (2) a flare of 
atopic dermatitis associated with milk ingestion along with a milk-specific IgE level > 5 
kUA/L. At entry, dietary, medical, and social histories were obtained by questionnaires 
administered to the parents of participants. Milk-specific IgE levels and milk skin prick test 
were performed at entry and periodically thereafter as clinically indicated. Atopic dermatitis 
severity was graded based on criteria previously described.1 Participants were evaluated in 
person at enrollment, 6 months, 12 months, and yearly thereafter with additional telephone 
follow-up between each visit. Milk allergy was considered persistent if the subject had milk 
allergy according to the above definitions at the last documented encounter.
We used logistic regression implemented in R 3.2.2 (R Foundation for Statistical 
Computing, Vienna, Austria) to test for the associations between early life exposures that 
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shaped the infant gut microbiome (mode of delivery, breastfeeding, solid food intake, 
antibiotic use) and milk allergy resolution by age 8 years or milk allergen sensitization.
Microbiome analyses
Based on observations from previous studies12,13 of marked shifts in the gut microbiome 
composition in early life associated with developmental stages (e.g. predominant nutrition 
from breastmilk and formula until age 6 months, predominant nutrition from solid food and 
transition to whole milk or milk alternatives around 12 months), we a priori stratified the 
participants into the following 3 groups for microbiome analysis: participants whose stool 
samples were obtained at (1) age 3 to 6 months, (2) age 7 to 12 months, and (3) age 13 to 16 
months. The members of the investigative team who conducted the microbiome and 
bioinformatic analyses had no role in acquiring or assessing the clinical results of the cohort 
study.
Unless noted otherwise, we performed all analyses using QIIME 1.8.0 (Quantitative Insights 
into Microbial Ecology), an open-source bioinformatics pipeline for performing analysis of 
microbiome sequence data. Operational taxonomic units (OTUs), defined as taxonomic units 
based on DNA sequences that share high identity14 were constructed using a >97% 
similarity threshold. Within the three age groups for analysis, alpha diversity (the richness of 
a sample in terms of the diversity of OTUs observed in it) was estimated using Faith’s 
phylogenetic diversity15. Beta diversity (distance between samples based on differences in 
OTUs present in each sample) was measured using unweighted UniFrac16. Principal 
coordinate analysis (PCoA) was used to visualize clustering patterns between samples based 
on beta diversity distances. Linear discriminant analysis effect size (LEfSe)17, a method for 
biomarker discovery, was used to determine taxa that best characterize each population, i.e. 
bacterial groups associated with milk allergy resolution or persistence. LEfSe scores 
measure the consistence of differences in relative abundance between taxa in the groups 
analyzed (i.e. resolution vs. persistence), with a higher score indicating higher consistency. 
Association between microbiome composition and covariates was tested using 
PERMANOVA, a non-parametric test similar to ANOVA but that does not require the data to 
be normally distributed. Significance of PERMANOVA tests was determined using 999 
permutations with adjustment for multiple testing.
Prediction of metagenome functional content
We used PICRUSt 1.0.0 (Phylogenetic Investigation of Communities by Reconstruction of 
Unobserved States)18 to predict metagenome function from the 16S rRNA data. Bray-Curtis 
distances were used to determine similarity of samples based on metagenomic composition. 
We used STAMP (Statistical Analysis of Metagenomic Profiles)19 to analyze the predicted 
metagenome and identify pathways associated with resolution or persistence of milk allergy. 
The Benjamini-Hochberg procedure was used to control the false discovery rate due to 
multiple testing.
Baseline characteristic comparisons and logistic regression results were considered 
statistically significant with unadjusted P <0.05, significant results from linear discriminant 
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analysis (LDA) required P < 0.05 and LDA score > 2.0, and PERMANOVA and 
metagenome analyses were considered statistically significant with adjusted P < 0.05.
Results
Study population
The baseline characteristics of the participants are shown in Table 1. The study population 
was mostly white (77%) with more male (65.9%) than female children. The majority of 
children had been born vaginally (61.9%) with about half breastfeeding and almost all 
(96.9%) taking solid foods at entry. The median age of participants at the time of stool 
collection was 10.6 months (IQR = 4.2) with a range of 3.6 to 16.9 months. The median age 
at last follow-up was 80.0 months (IQR = 18.0), with no significant difference in age at last 
follow-up between those with resolution or persistence of milk allergy. Participants whose 
milk allergy resolved by age 8 years had significantly smaller milk SPT, lower milk sIgE 
levels, and milder atopic dermatitis at entry.
The baseline characteristics of the participants stratified by age at stool collection (age 3–6 
months (n=29), 7–12 months (n=144), 13–16 months (n=53)) are shown in Supplementary 
Table 1.
There were no associations between early life exposures that shaped the infant gut 
microbiome (mode of delivery, breastfeeding, solid food intake, antibiotic use) and milk 
allergy resolution by age 8 years or milk allergen sensitization (Supplementary Table 2).
Distinct gut microbiome in 3–6 month old subjects with milk allergy resolution by age 8 
years
Subjects sampled at age 3–6 months who achieved milk allergy resolution by age 8 years 
had a distinct gut microbiome composition compared to subjects sampled at the same age 
whose milk allergy persisted (PERMANOVA P = 0.047). This distinction was not observed 
in subjects sampled later in life at age 7–12 months (PERMANOVA P = 0.39) or at age 13–
16 months (PERMANOVA P = 0.96). There were no significant effects of antibiotic use or 
atopic dermatitis severity on bacterial composition in the subjects sampled at age 3- 6 
months (PERMANOVA P = 0.53 and 0.80, respectively), indicating that neither antibiotic 
use nor atopic dermatitis were confounders of the association between gut microbiome 
composition and milk allergy resolution. Results from linear discriminant analysis effect size 
(LEfSe) and principal coordinate analysis (PCoA) confirmed the distinct gut microbiome 
composition associated with milk allergy resolution.
Linear discriminant analysis revealed distinct taxa in the microbiome of 3–6 month subjects 
with milk allergy resolution vs. milk allergy persistence (Figure 1). Among subjects sampled 
at age 3–6 months, the Firmicutes phylum and Clostridia class were enriched in the infant 
gut microbiome of subjects whose milk allergy resolved by age 8 years, while Bacteroidetes 
and Enterobacter, were characteristic of subjects whose milk allergy did not resolve by age 8 
years (Figure 1b). These findings were consistent when covariates (antibiotics, solid food 
intake, mode of delivery, race, and breastfeeding) were taken into account in the LEfSe 
analysis (Supplementary Figure 1).
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PCoA demonstrated separation in gut microbiome composition between subjects sampled at 
age 3–6 months who achieved milk allergy resolution vs. subjects with persistent milk 
allergy (Figure 2a). PCoA did not show separation reflecting distinct gut microbiome 
composition related to milk allergy resolution in subjects sampled at age 7–12 or 13–16 
months (Figures 2b and 2c).
Trend toward increased bacterial diversity in subjects with milk allergy resolution by age 8 
years
Compared to subjects whose milk allergy did not resolve by mid-childhood, the gut 
microbiome of participants with milk allergy resolution showed a trend of increased 
bacterial diversity. This trend was most pronounced in subjects sampled at age 3–6 months, 
with decreasing difference in those sampled at age 7–12 months and little difference at age 
13–16 months (Figure 3).
Distinct metagenome in subjects with milk allergy resolution
PCoA of predicted metagenome function showed a significant separation in bacterial 
functional pathways related to milk allergy resolution in subjects sampled at age 3–6 months 
(Figure 4a, PERMANOVA P = 0.004), but not in those sampled later in life (Figures 4b and 
4c, PERMANOVA P = 0.79 at age 7–12 months and PERMANOVA P = 0.72 at age 13–16 
months). The only metabolic pathway that was differentially enriched in the metagenome of 
subjects sampled at age 3–6 months was fatty acid metabolism, which was decreased (η2 = 
0.43, P = 0.034) in subjects whose milk allergy resolved (Figure 5 and Supplementary Table 
3). Subjects sampled at older ages did not show differential abundance of any metabolic 
pathways (Supplementary Table 3).
Correlation between gut microbiome diversity, composition, and milk sIgE level or milk 
SPT
Milk sIgE levels or milk SPT size at baseline, change in levels, or slope of these measures 
over time were not significantly correlated with abundance of any microbial taxa. Alpha 
diversity was not significantly correlated with milk sIgE in any age group (PERMANOVA P 
= 0.40 in age 3–6 months; PERMANOVA P = 0.08 in age 7–12 months; PERMANOVA P = 
0.18 in age 13–16 months), nor with milk SPT in any age group (PERMANOVA P = 0.32 in 
age 3–6 months; PERMANOVA P = 0.10 in age 7–12 months; PERMANOVA P = 0.27 in 
age 13–16 months).
Discussion
We found that gut microbiome composition of milk allergic children was associated with 
resolution of milk allergy by age 8 years, with enrichment of Clostridia and Firmicutes in 
the 3–6 month old gut microbiome of subjects whose milk allergy later resolved. Our 
examination of predicted metagenome function showed differential bacterial function 
associated with milk allergy resolution, with decreased fatty acid metabolism in resolvers.
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Comparison with other studies
Our study is the first to examine the relationship between the microbiome and food allergy 
resolution. Previous studies have examined associations between the gut microbiome and 
food allergy status. Using bacterial cultures, Thompson-Chagoyan et al. found that 
compared to healthy infants, cow’s milk allergic infants had higher total bacteria and 
anaerobic counts; after 6 months during which milk allergic subjects took extensively 
hydrolyzed formula and healthy control subjects took cow’s milk formula, the milk allergic 
group had higher proportions of lactobacilli and lower proportions of enterobacteria and 
bifidobacteria.10 Major limitations of this study included reliance on bacterial culture (which 
cannot characterize the majority of bacterial taxa, which are unculturable) and differential 
diet as a confounder of the association between gut microbiome and food allergy status. 
Ling et al. reported enrichment of Clostridium sensu stricto, Butyricicoccus, Clostridicaceae 
1, and Ruminococcaceae sequences in 34 Chinese infants with food allergy to a variety of 
foods compared to 45 healthy controls, but half of the “food allergic” had non-IgE-mediated 
food allergy.20 Employing a murine model of food allergy, Noval Rivas et al. reported that 
OVA-sensitized Il4raF709 mice had differential abundance of Lachnospiraceae, 
Lactobacillacaeae, Rikenallaceae, and Porphyromononadaceae compared to wild type mice, 
and reconstitution of wildtype mice with the microbiota from these allergen-sensitized mice 
promoted OVA-specific IgE responses.21 Although the above studies reported differences in 
bacterial composition related to food allergy status, none examined resolution of food 
allergy as we did in this study.
We found taxa from the Clostridia class and Firmicutes phylum to be enriched in human 
subjects with milk allergy resolution. Such taxa have been previously linked to immune 
tolerance in mouse models of allergy and protection from allergic inflammation in subjects 
with eosinophilic esophagitis. Atarashi et al. identified 17 strains of bacteria from human 
stool that enhanced Treg cell abundance and induced key anti-inflammatory markers such as 
IL-10 and inducible T-cell co-stimulator (ICOS) in Treg cells upon inoculation into germ-
free mice, with genome sequencing revealing that all 17 strains were taxa within 
Clostridia.22 Oral administration of these 17 Clostridia strains into mice attenuated disease 
in models of colitis and allergic diarrhea.22 Stefka et al. found that gnotobiotic mice 
colonized with Clostridium clusters protected against sensitization to peanut/cholera toxin, 
with reduced levels of peanut-specific and total IgE compared to germ-free controls and no 
temperature drop upon allergen challenge.23 Additionally, Clostridia-colonized mice had 
significantly increased proportions of Foxp3+ Tregs in their colonic lamina propria and 
increased concentrations of fecal IgA compared to germ-free mice.23 Clostridia colonization 
induced IL-22 production by RORgt+ innate lymphoid cells and T cells, which reduced the 
concentration of serum allergen, supporting the concept that Clostridia play a critical role in 
regulating sensitization to food allergens.23 A strength of our study is that in contrast to 
these previous murine studies, it provides human data to support that Clostridia play a role in 
allergy and inflammation. With regards to Firmicutes, a study of 33 pediatric subjects with 
eosinophilic esophagitis and 35 normal controls showed that taxa from the Firmicutes 
phylum predominated the esophageal microbiota of control subjects.24
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The gut microbiome of our 3–6 month subjects with persistent milk allergy was enriched 
with taxa from phylum Bacteroidetes, which is consistent with a prior study demonstrating a 
predominance of this phylum in infants with milk allergy and high risk of chronic allergic 
disease. Specifically, Kirjavainen et al. found high abundance of Bacteroides in the gut 
microbiome of infants with a high degree of milk allergy (as demonstrated by reaction to 
extensively hydrolyzed formula), early onset atopic eczema, and a strong family history of 
atopic disorders.25 Our results and those of Kirjavainen et al. are in contrast to findings from 
murine models, where colonization with Bacteroides were observed to correct Th1/Th2 
imbalances26 and induce regulatory T cell development.27,28
The results of our predicted metagenome analyses showed that bacterial functional pathways 
related to fatty acid metabolism were significantly reduced in subjects whose milk allergy 
resolved with time. This finding suggests that decreased fatty acid metabolism by gut 
microbiota may be helpful toward reducing long-term allergy risk. Gas liquid 
chromatography studies of infant stool composition show lower levels of branched-chain 
short fatty acids in healthy infants relative to cow’s milk allergic infants.29 These levels were 
observed cross-sectionally, so it is not known if lower levels of fatty acids would be found in 
infants whose milk allergy resolved with time versus those with persistent milk allergy. 
Overall, lipids are known to facilitate the passage of food allergens through intestinal 
epithelial barriers and affect the allergenicity of food proteins.30 Lipids in cow’s milk itself 
can induce the expansion of iNKT cells and release of IL-4, IL-5, and IL-13, leading to a 
Th2-dominant milieu.31 Attenuation of such lipid-driven pro-inflammatory effects would be 
ostensibly beneficial in allergy resolution, and our results suggest that gut microbiota may 
contribute to this via reduced fatty acid metabolism.
Early infancy as a time window shaping the course of food allergy
The associations between microbiome composition, metagenome functional content, and 
milk allergy resolution were specific to subjects sampled at 3–6 months in our study, with no 
significant associations in subjects sampled at 7–12 months or 13–16 months. Two potential 
interpretations of this include: (1) early infancy (i.e. 3–6 months) is a particular 
developmental time window during which gut microbiota shapes the course of food allergy, 
and gut microbiota at later ages (e.g. 7–16 months) have little effect on food allergy course, 
and (2) gut microbiota is associated with food allergy course at different age stages, but 
confounders obscure this signal when subjects are sampled at > 6 months age. Early infancy 
could be a key developmental time window, as we and others have shown age-dependent 
associations between infant gut microbiome and allergy. Azad and colleagues found that gut 
microbial richness at age 3 months was associated with increased likelihood of food 
sensitization by 1 year, while there was no association between microbial richness at 12 
months and food sensitization.32 Similarly, Abrahamsson et al. found that gut microbiota 
diversity at age 1 month but not at age 12 months was associated with atopic dermatitis 
during the first 2 years of life.33 Porcine models have shown that the postnatal environment 
from as early as the first day of life influences gut microbiota and subsequent metabolic 
phenotypes.34 Murine models also support that age-sensitive contact with microbiota is 
critical for establishing tolerance to later exposures.35 Our collective findings support the 
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theory that factors influencing early immune system development may be particularly 
important for subsequent allergy development.36
However, the intestinal microbiome in early life is markedly dynamic with dramatic shifts 
after the introduction of solid foods leading to an “adult-like” profile.12,37 Thus, it is 
possible that associations between gut microbiota and allergy outcomes are obscured after 
the introduction of solid food in the diet, e.g. at approximately 6 months of age.
No association between gut microbiota and milk-specific IgE or milk SPT
We did not find an association between gut microbiota and sensitization (by sIgE or SPT) to 
milk at baseline, confirming previously reported results. Adlerberth et al. found no 
association between culturable bacteria and food sensitization by 18 months in 3 cohorts of 
European infants.8 Similarly, Kendler et al. reported no association between culturable gut 
microbiota and sensitization to common food allergens including milk, casein, egg, peanut 
and hazelnut.38 Experimental models suggest that food antigen sensitization results from 
inhibition of the immune system default of tolerance.39. The cross-sectional design of our 
study precludes us from determining whether changes over time in gut microbiota 
composition correlate with the decline in IgE levels associated with food allergy resolution. 
It is also possible that the mechanisms by which early life microbiome composition are 
associated with resolution are indirect through the production of bacterial metabolites. 
Indeed, short-chain fatty acids such as butyrate have been shown to have anti-inflammatory 
properties23 and to regulate macrophage function.40 Overall, our results suggest that gut 
microbiota may not play a direct role in tolerance inhibition leading to food allergen 
sensitization, but may instead help reestablish the default state of tolerance.
Limitations and future directions
Although we examined the gut microbiome of 226 subjects with milk allergy, significant 
associations between gut microbiome composition, predicted metagenome function, and 
milk allergy resolution were observed only in those sampled at age 3–6 months. This subset 
proved to be informative and supports the notion that the gut microbiome of young infants 
may be of particular interest and should be targeted with larger sample sizes in future studies 
that include longitudinal sampling. We note that previous studies of the early-life 
microbiome have had similar or smaller sample size for young infants41,42 A secondary 
analysis of microbiota associated with tolerance of baked milk would have been of interest, 
but we did not characterize baked milk consumption in a rigorous manner. Ability to 
consume products with baked milk is associated with accelerated resolution of milk 
allergy.43,44 Additionally, although our findings support the concept that specific gut 
microbial taxa are associated with milk allergy resolution, we caution that our results cannot 
determine causality and do not imply that probiotic supplementation with these taxa should 
be implemented as treatment for milk allergy without prospective study. Probiotic 
supplementation, particularly with Lactobacillus and Bifidobacterium species, has been 
explored as potential treatment for cow’s milk allergy in randomized controlled trials with 
mixed results.45,46 The taxa we identified differ from those already targeted and would 
require prospective study for efficacy as well as safety before their potential use as treatment 
for cow’s milk allergy.41
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Conclusions
We found enrichment of Clostridia and Firmicutes in the infant gut microbiome of 3–6 
month old subjects whose milk allergy resolved by age 8 years. The microbiota of these 
young infants whose milk allergy resolved were associated with decreased fatty acid 
metabolism. Our results are the first to address the relationship between gut microbiota and 
food allergy resolution, and our findings suggest directions for prospective examination of 
the highlighted taxa for potential therapeutic consideration. Early infancy is a window 
during which gut microbiota may shape food allergy outcomes in childhood.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Key messages
• Clostridia and Firmicutes were enriched in the gut microbiome of milk 
allergic children at age 3–6 months whose milk allergy resolved by age 
8 years.
• Metagenome functional prediction showed decreased fatty acid 
metabolism in the early infant gut microbiome of children whose milk 
allergy resolved.
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Capsule summary
Examination of early-life gut microbiota in milk allergic children from a longitudinal, 
multicenter observational study showed that Clostridia and Firmicutes are associated with 
resolution of milk allergy.
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Figure 1. Linear discriminant analysis shows distinct gut microbiome composition associated 
with milk allergy resolution
Taxa within Clostridia and Firmicutes were enriched in children sampled at age 3–6 months 
with milk allergy resolution vs. milk allergy persistence by age 8 years, while taxa within 
Bacteroidetes were underrepresented. (a) Linear Discriminant Analysis scores as calculated 
by LEfSe of taxa differentially abundant in milk allergy resolution and milk allergy 
persistence (b) LEfSe cladogram representing differentially abundant taxa. All taxa were 
significantly associated with either resolution or persistence of milk allergy (P < 0.05). Only 
taxa with LDA scores >2 are presented.
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Figure 2. Principal coordinate analysis shows separation of bacterial composition at age 3–6 
months associated with milk allergy resolution
PCoA plots of bacterial composition and diversity of the gut microbiome of children 
sampled at age (a) 3–6 months, (b) 7–12 months, and (c) 13–16 months. Plots are based on 
unweighted UniFrac distances, with each point corresponding to a subject and colored by 
milk allergy resolution vs. milk allergy persistence by age 8 years. Only children sampled at 
age 3–6 months had a significantly distinct microbiome composition associated with milk 
allergy resolution by age 8 years (PERMANOVA P = 0.047).
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Figure 3. Trend toward increased bacterial diversity in subjects with milk allergy resolution by 
age 8 years
Rarefaction curves for bacterial diversity of the gut microbiome of children sampled at age 
(a) 3–6 months, (b) 7–12 months, and (c) 13–16 months. The vertical axis indicates alpha 
diversity measured using Faith’s phylogenetic diversity, while the horizontal axis indicates 
sequencing depth. Mean and standard deviation alpha diversity at each sequencing depth 
were estimated by subsampling all samples 10 times at the specified rarefaction.
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Figure 4. Principal coordinate analysis shows separation of metagenome functional content at 
age 3–6 months associated with milk allergy resolution
PCoA plots of metagenome functional content of the gut microbiome of children sampled at 
age (a) 3–6 months, (b) 7–12 months, and (c) 13–16 months. Plots are based on Bray-Curtis 
distances, with each point corresponding to a subject and colored by milk allergy resolution 
vs. milk allergy persistence by age 8 years. Only children sampled at age 3–6 months had a 
significantly distinct metagenome composition associated with milk allergy resolution by 
age 8 years (PERMANOVA P = 0.004).
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Figure 5. Metagenome functional enrichment of fatty acid metabolism in milk allergy persistence
Prediction of metagenome functional content using PICRUSt showed differential enrichment 
of fatty acid metabolism pathways in children sampled at age 3–6 months (η2 = 0.43, 
ANOVA Pcorrected = 0.034). The vertical axis indicates the relative abundance of predicted 
KEGG orthologs annotated as being part of fatty acid metabolism. Error bars indicate 
standard deviation from the mean. Supplementary Table 3 includes information on all 
pathways.
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Table 1
Baseline characteristics of the participating subjects with milk allergy
Characteristics All subjects with
milk allergy
included in the
analysis
Milk allergy
persistent at
age 8 years
Milk allergy
resolved by
age 8 years
P value*
Subjects 226 98 (43.4%) 128 (56.6%)
Age at stool collection 0.83
    3–6 months 29 11 (37.9%) 18 (62.1%)
    7–12 months 144 64 (44.4%) 80 (55.6%)
    13–16 months 53 23 (43.4%) 30 (56.6%)
Age at last followup (months) –
median (IQR)
80.0 (18.0) 79.9 (18.4) 80 (15.8) 0.68^
Sex 1.0
    Female 77 33 (42.9%) 44 (57.1%)
    Male 149 65 (43.6%) 84 (56.4%)
Race 0.13
    White 174 72 (41.4%) 102 (58.6%)
    Black/African-American 30 12 (40.0%) 18 (60.0%)
    Asian 19 13 (68.4%) 6 (31.6%)
    Other 3 1 (33.3%) 2 (66.7%)
Baseline milk IgE level 2.1 × 10–9
    <2 91 20 (22.0%) 71 (78.0%)
    ≥ 2–10 68 30 (44.1%) 38 (55.9%)
    >10 67 48 (71.6%) 19 (28.4%)
Baseline milk SPT response
(wheal in mm)
1.1 × 10–5
    <5 63 12 (19.0%) 51 (81.0%)
    5–10 82 41 (50.0%) 41 (50.0%)
    >10 81 45 (55.6%) 36 (44.4%)
Baseline AD severity 0.02
    None 29 6 (20.7%) 23 (79.3%)
    Mild 32 11 (34.4%) 21 (65.6%)
    Moderate 126 62 (49.2%) 64 (50.8%)
    Severe 39 19 (48.7%) 20 (51.3%)
Breast-feeding at entry 0.47
    Never 36 14 (38.9%) 22 (61.1%)
    Yes, currently 115 47 (40.9%) 68 (59.1%)
    Yes, but no longer 75 37 (49.3%) 38 (50.7%)
Mode of delivery** 0.78
    Vaginal 140 62 (44.3%) 78 (55.7%)
    C-section 85 36 (42.4%) 49 (57.6%)
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Characteristics All subjects with
milk allergy
included in the
analysis
Milk allergy
persistent at
age 8 years
Milk allergy
resolved by
age 8 years
P value*
Solid food intake 0.70
    Yes 219 96 (43.8%) 123 (56.2%)
    No 7 2 (28.6%) 5 (71.4%)
Antibiotics – lifetime prior to
sampling
0.89
    Yes 142 61 (43.0%) 81 (57.0%)
    No 84 37 (44.0%) 47 (56.0%)
*
Fisher Exact test
^Wilcoxon rank sum test
**
Data N/A for 1 subject
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